Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse panbronchiolitis in East Asia.

Arata Azuma1, Shoji Kudoh

  • 1Respiratory Medicine of Nippon Medical School, Tokyo, Japan. a-azuma@nms.ac.jp

Respirology (Carlton, Vic.)
|April 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pamufetinib (TAS-115) for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A double-blind, multicenter, phase 2b Clinical Trial.

American journal of respiratory and critical care medicine·2026
Same author

Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.

The European respiratory journal·2026
Same author

Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trial.

American journal of respiratory and critical care medicine·2026
Same author

Diaphragmatic curvature analysis using dynamic digital radiography.

European journal of radiology open·2025
Same author

Dynamic Chest Radiography versus Pulmonary Function Tests in Chronic Obstructive Pulmonary Disease.

Radiology·2025
Same author

Erector spinae muscle thickness predicts mortality in patients with pulmonary diseases.

Respiratory investigation·2025
Same journal

High-Flow Nasal Oxygen in Early Home Pulmonary Rehabilitation for Exertional Hypoxaemia: A Pilot Randomised Feasibility Trial.

Respirology (Carlton, Vic.)·2026
Same journal

Contemporary Concise Review 2025: Asthma.

Respirology (Carlton, Vic.)·2026
Same journal

Early Intervention With Biologics for Asthma Remission: Promising or Premature?

Respirology (Carlton, Vic.)·2026
Same journal

Clinical and Inflammatory Phenotypes During Exacerbations Predict In-Hospital Adverse Outcomes in Asthma-COPD Overlap.

Respirology (Carlton, Vic.)·2026
Same journal

Diagnostic Yield of EBUS Mediastinal Cryobiopsy Versus TBNA in Suspected Lymphoproliferative Disorders: A Prospective Multicentre Study.

Respirology (Carlton, Vic.)·2026
Same journal

Association of Airway Mucus Plugs and Physical Activity, Exercise Tolerance, Sarcopenia, and Frailty in Patients With COPD and Pre-COPD.

Respirology (Carlton, Vic.)·2026
See all related articles

Diffuse panbronchiolitis, a chronic sinobronchial disease prevalent in East Asia, shows promising treatment with macrolides. Research explores macrolides’ anti-inflammatory effects beyond bactericidal action for better therapeutic strategies.

Area of Science:

  • Pulmonology
  • Immunology
  • Pharmacology

Background:

  • Diffuse panbronchiolitis (DPB) is a chronic sinobronchial infection with characteristic lung lesions, predominantly affecting East Asian populations.
  • Genetic predisposition, potentially linked to human leucocyte antigen loci, is suspected in DPB's uneven distribution.
  • Low-dose, long-term macrolide therapy, initially observed in a single erythromycin-treated case, has emerged as a significant treatment approach.

Purpose of the Study:

  • To review the incidence, pathology, and treatment of diffuse panbronchiolitis in East Asia.
  • To investigate the mechanisms underlying the effectiveness of macrolide therapy in DPB.
  • To explore potential new therapeutic strategies targeting macrolide's anti-inflammatory properties.

Main Methods:

Related Experiment Videos

  • Literature review focusing on DPB incidence, clinical profile, and macrolide therapy history.
  • Analysis of proposed mechanisms of macrolide action, including anti-inflammatory effects.
  • Discussion of intracellular mechanisms and the development of non-antimicrobial macrolide analogues.

    • Main Results:

    • Macrolide therapy demonstrates effectiveness in DPB, with proposed mechanisms including reduced mucus/water secretion, inhibited inflammatory cell accumulation, and attenuated bacterial virulence.
    • The anti-inflammatory activity of macrolides is distinct from their bactericidal effects.
    • Intracellular mechanisms of macrolide action are a key area of ongoing research.

    Conclusions:

    • Macrolide therapy is a valuable treatment for diffuse panbronchiolitis, with anti-inflammatory actions being crucial.
    • Developing novel anti-inflammatory macrolide analogues could offer safer and more effective treatments, minimizing antimicrobial resistance.
    • Further research into intracellular macrolide mechanisms is warranted for optimizing DPB management.